Changjiang Runfa Medicine Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Changjiang Runfa Medicine Co Ltd with three other
companies in this sector in China:
Hunan ER-KANG Pharmaceutical Co Ltd
sales of 2.83 billion Chinese Renmimbi [US$409.85 million]
of which 88%
was Manufacture of Medicines),
Zhejiang Jianfeng Group Company Limited
(2.83 billion Chinese Renmimbi [US$409.65 million]
of which 45%
was Cement/Construction Materials), and
Shandong Jincheng Pharmaceutical Group Co Ltd
(2.79 billion Chinese Renmimbi [US$404.07 million]
of which 72%
was Medicine Manufacturing).
During the year ended December of 2017, sales at
Changjiang Runfa Medicine Co Ltd were 2.99 billion Chinese Renmimbi (US$432.90 million).
increase of 41.2%
versus 2016, when the company's sales were 2.11 billion Chinese Renmimbi.
Sales of Medicine saw an increase
65.7% in 2017, from
1.16 billion Chinese Renmimbi to 1.92 billion Chinese Renmimbi.